Heber, D. et al. Clinical detection of sarcopenic obesity by bioelectrical impedance analysis. Am. J. Clin. Nutr. 64, 472s–477s (1996).
Article CAS PubMed Google Scholar
Donini, L. M. et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Clin. Nutr. 41, 990–1000 (2022). Collaboration between ESPEN and EASO has established a unified definition and diagnostic criteria for sarcopenic obesity, aiming to streamline research and treatment approaches for this prevalent condition.
Article CAS PubMed Google Scholar
Donini, L. M. et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes. Facts 15, 321–335 (2022).
Article PubMed PubMed Central Google Scholar
Roubenoff, R. Sarcopenic obesity: the confluence of two epidemics. Obes. Res. 12, 887–888 (2004). This commentary discusses how the convergence of the obesity epidemic with an ageing population magnifies the risk of sarcopenic obesity, posing unprecedented health challenges and underscoring the urgent need for interdisciplinary collaboration.
Gao, Q. et al. Global prevalence of sarcopenic obesity in older adults: a systematic review and meta-analysis. Clin. Nutr. 40, 4633–4641 (2021).
Donini, L. M. et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review. Clin. Nutr. 39, 2368–2388 (2020). This systematic review, sponsored by ESPEN and EASO, examines various definitions and diagnostic criteria for sarcopenic obesity across studies, highlighting significant inconsistencies and emphasizing the urgent need for a universally accepted definition, diagnostic standards and relevant cut-off values to improve research, prevalence assessments and intervention strategies.
Murdock, D. J. et al. The prevalence of low muscle mass associated with obesity in the USA. Skelet. Muscle 12, 26 (2022).
Article CAS PubMed PubMed Central Google Scholar
Kirwan, R. et al. Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss. Geroscience 42, 1547–1578 (2020).
Article PubMed PubMed Central Google Scholar
Montes-Ibarra, M. et al. The impact of long COVID-19 on muscle health. Clin. Geriatr. Med. 38, 545–557 (2022).
Article PubMed PubMed Central Google Scholar
Montes-Ibarra, M. et al. Prevalence and clinical implications of abnormal body composition phenotypes in patients with COVID-19: a systematic review. Am. J. Clin. Nutr. 117, 1288–1305 (2023).
Article CAS PubMed Google Scholar
Stenholm, S. et al. Sarcopenic obesity: definition, cause and consequences. Curr. Opin. Clin. Nutr. Metab. Care 11, 693–700 (2008).
Article PubMed PubMed Central Google Scholar
Siervo, M. et al. Body composition indices of a load-capacity model: gender- and BMI-specific reference curves. Public. Health Nutr. 18, 1245–1254 (2015).
Wells, J. C. Historical cohort studies and the early origins of disease hypothesis: making sense of the evidence. Proc. Nutr. Soc. 68, 179–188 (2009).
Prado, C. M. M., Wells, J. C. K., Smith, S. R., Stephan, B. C. M. & Siervo, M. Sarcopenic obesity: a critical appraisal of the current evidence. Clin. Nutr. 31, 583–601 (2012). This review highlights the significance of sarcopenic obesity due to its dual metabolic burden, and underscores the inconsistency in study methodologies.
Article CAS PubMed Google Scholar
Baumgartner, R. N. & Waters, D. L. in Principles and Practice of Geriatric Medicine (eds Pathy, M. S. J., Sinclair, A. J. & Morley, J. E.) 909–933 (Wiley, 2005).
Cruz-Jentoft, A. J., Gonzalez, M. C. & Prado, C. M. Sarcopenia ≠ low muscle mass. Eur. Geriatr. Med. 14, 225–228 (2023).
Baumgartner, R. N. Body composition in healthy aging. Ann. N. Y. Acad. Sci. 904, 437–448 (2000).
Article CAS PubMed Google Scholar
Baumgartner, R. N. et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes. Res. 12, 1995–2004 (2004). This is one of the first studies to show that older adults with sarcopenic obesity are two to three times more likely to experience a decline in daily activity capabilities, underscoring the independent link between sarcopenic obesity and the onset of functional limitations in community-dwelling seniors.
Bahat, G., Kilic, C., Ozkok, S., Ozturk, S. & Karan, M. A. Associations of sarcopenic obesity versus sarcopenia alone with functionality. Clin. Nutr. 40, 2851–2859 (2021).
Misra, D. et al. Risk of knee osteoarthritis with obesity, sarcopenic obesity, and sarcopenia. Arthritis Rheumatol. 71, 232–237 (2019).
Article PubMed PubMed Central Google Scholar
Atmis, V. et al. The relationship between all-cause mortality sarcopenia and sarcopenic obesity among hospitalized older people. Aging Clin. Exp. Res. 31, 1563–1572 (2019).
Batsis, J. A., Mackenzie, T. A., Jones, J. D., Lopez-Jimenez, F. & Bartels, S. J. Sarcopenia, sarcopenic obesity and inflammation: results from the 1999–2004 National Health and Nutrition Examination Survey. Clin. Nutr. 35, 1472–1483 (2016).
Article PubMed PubMed Central Google Scholar
Chung, J. H., Hwang, H. J., Shin, H.-Y. & Han, C. H. Association between sarcopenic obesity and bone mineral density in middle-aged and elderly Korean. Ann. Nutr. Metab. 68, 77–84 (2015).
Fábrega-Cuadros, R. et al. Associations of sleep and depression with obesity and sarcopenia in middle-aged and older adults. Maturitas 142, 1–7 (2020).
Gandham, A. et al. Falls, fractures, and areal bone mineral density in older adults with sarcopenic obesity: a systematic review and meta-analysis. Obes. Rev. 22, e13187 (2021).
Article CAS PubMed Google Scholar
Gao, Q. et al. Prevalence and prognostic value of sarcopenic obesity in patients with cancer: a systematic review and meta-analysis. Nutrition 101, 111704 (2022).
Gortan Cappellari, G. et al. Sarcopenic obesity: what about in the cancer setting? Nutrition 98, 111624 (2022).
Ishii, S. et al. The association between sarcopenic obesity and depressive symptoms in older Japanese adults. PLoS ONE 11, e0162898 (2016).
Article PubMed PubMed Central Google Scholar
Frisoli, A. Jr et al. Sarcopenic obesity definitions and their associations with physical frailty in older Brazilian adults: data from the SARCOS study. Arch. Endocrinol. Metab. 67, 361–371 (2023).
PubMed PubMed Central Google Scholar
Juez, L. D. et al. Impact of sarcopenic obesity on long-term cancer outcomes and postoperative complications after gastrectomy for gastric cancer. J. Gastrointest. Surg. 27, 35–46 (2023).
Kim, M. K. et al. Vitamin D deficiency is associated with sarcopenia in older Koreans, regardless of obesity: the fourth Korea National Health and Nutrition Examination Surveys (KNHANES IV) 2009. J. Clin. Endocrinol. Metab. 96, 3250–3256 (2011).
Article CAS PubMed Google Scholar
Kobayashi, A. et al. Impact of sarcopenic obesity on outcomes in patients undergoing hepatectomy for hepatocellular carcinoma. Ann. Surg. 269, 924–931 (2019).
Lee, S. E., Park, J.-H., Kim, K.-A., Kang, Y.-S. & Choi, H. S. Association between sarcopenic obesity and pulmonary function in Korean elderly: results from the Korean National Health and Nutrition Examination Survey. Calcif. Tissue Int. 106, 124–130 (2020).
Article CAS PubMed Google Scholar
Liao, C.-D., Huang, S.-W., Huang, Y.-Y. & Lin, C.-L. Effects of sarcopenic obesity and its confounders on knee range of motion outcome after total knee replacement in older adults with knee osteoarthritis: a retrospective study. Nutrients 13, 3817 (2021).
Article PubMed PubMed Central Google Scholar
Liu, C. et al. Deciphering the “obesity paradox” in the elderly: a systematic review and meta-analysis of sarcopenic obesity. Obes. Rev. 24, e13534 (2023).
Article CAS PubMed Google Scholar
Mintziras, I. et al. Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: systematic review and meta-analysis. Int. J. Surg. 59, 19–26 (2018).
Murawiak, M. et al. Sarcopenia, obesity, sarcopenic obesity and risk of poor nutritional status in Polish community-dwelling older people aged 60 years and over. Nutrients 14, 2889 (2022).
Article PubMed PubMed Central Google Scholar
Pedrazzani, C. et al. Impact of visceral obesity and sarcobesity on surgical outcomes and recovery after laparoscopic resection for colorectal cancer. Clin. Nutr. 39, 3763–3770 (2020).
Article CAS PubMed Google Scholar
Pilati, I., Slee, A. & Frost, R. Sarcopenic obesity and depression: a systematic review. J. Frailty Aging 11, 51–58 (2022).
Rossi, A. P. et al. Dynapenic abdominal obesity as a predictor of worsening disability, hospitalization, and mortality in older adults: results from the InCHIANTI study. J. Gerontol. A Biol. Sci. 72, 1098–1104 (2017). This study reveals that older adults with dynapenic abdominal obesity have an increased risk of disability progression, hospitalization and death.
留言 (0)